BioNTech is acquiring CureVac in a deal that brings messenger RNA manufacturing capability and cancer immunotherapy ...

The Food and Drug Administration (FDA) expanded the approval of Moderna’s RSV vaccine late Thursday to include people 18 to ...

For a long time, scientists depended on luck to find new proteins. In 1840, for example, Friedrich Ludwig Hünefeld, a German ...

RNA gene scissors (CRISPR-Cas13) are gaining significant attention as a next-generation gene therapy with fewer side effects.

Researchers in Australia use COVID-era mRNA technology to expose hidden HIV in white blood cells, offering hope for a future ...

The recent downturn in biotech has battered Massachusetts’ world-renowned sector, and the political climate has only made it ...

Researchers have developed a lung-targeted nanoparticle delivery system for genetic therapies. In a major step forward for ...

A scientific team has unlocked a new way to treat serious lung conditions by using specially designed nanoparticles to ...

The FDA expanded the approval of Moderna’s RSV vaccine, extending the license to include more adults and giving the company a welcome win.

Replacing some chemical pesticides with potentially safer, more environmentally benign alternatives is a significant ...

Moderna vaulted to the forefront of biotech, becoming a major pillar of the region’s economy. But Robert F. Kennedy Jr.’s ...